Publications by authors named "Harold Marcotte"

Claim this Profile
E
Evaluation of two IgG-scFv bispecific antibodies for neutralizing Omicron variants of SARS-CoV-2.
Diana Hinojosa-Trujillo, Freddy Dehesa-Canseco, Melissa García-Vega, Verónica Mata-Haro, Mario Solís-Hernández, Harold Marcotte

J Virol Methods· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ultrapotent IgA dimeric antibodies neutralize emerging Omicron variants.
Fanglei Zuo, Yunlong Cao, Rui Sun, Qianran Wang, Luca Simonelli, Harold Marcotte

J Virol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative single-cell transcriptomic profile of hybrid immunity induced by adenovirus vector-based COVID-19 vaccines.
Melissa García-Vega, Hui Wan, Mónica Reséndiz-Sandoval, Diana Hinojosa-Trujillo, Olivia Valenzuela, Harold Marcotte

Genes Immun· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutralisation activity of mucosal IgA against XBB sublineages and BA.2.86.
Fanglei Zuo, Yunlong Cao, Rui Sun, Ayijiang Yisimayi, Likun Du, Harold Marcotte

Lancet Infect Dis· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conversion of monoclonal IgG to dimeric and secretory IgA restores neutralizing ability and prevents infection of Omicron lineages.
Harold Marcotte, Yunlong Cao, Fanglei Zuo, Luca Simonelli, Josè Camilla Sammartino

Proc Natl Acad Sci U S A· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, structure and plasma binding of ancestral β-CoV scaffold antigens.
David Hueting, Karen Schriever, Rui Sun, Stelios Vlachiotis, Fanglei Zuo, Harold Marcotte

Nat Commun· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination with attachment proteins protects against gastric cancer.
Jeanna A Bugaytsova, Artem Piddubnyi, Iryna Tkachenko, Lena Rakhimova, Johan Olofsson Edlund, Harold Marcotte

bioRxiv· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
attachment-blocking antibodies protect against duodenal ulcer disease.
Jeanna A Bugaytsova, Kristof Moonens, Artem Piddubnyi, Alexej Schmidt, Johan Olofsson Edlund, Harold Marcotte

bioRxiv· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
19n01, a broadly neutralizing antibody against omicron BA.1, BA.2, BA.4/5, and other SARS-CoV-2 variants of concern.
Melissa García-Vega, Edgar A Melgoza-González, Sofía Hernández-Valenzuela, Diana Hinojosa-Trujillo, Mónica Reséndiz-Sandoval, Harold Marcotte

iScience· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterologous inactivated virus/mRNA vaccination response to BF.7, BQ.1.1, and XBB.1.
Fanglei Zuo, Rui Sun, Hassan Abolhassani, Likun Du, Yating Wang, Harold Marcotte

Lancet Reg Health West Pac· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoprotein.
Filippo Bianchini, Virginia Crivelli, Morgan E Abernathy, Concetta Guerra, Martin Palus, Harold Marcotte

Sci Immunol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lactobacilli as a Vector for Delivery of Nanobodies against Norovirus Infection.
Yoshikazu Yuki, Fanglei Zuo, Shiho Kurokawa, Yohei Uchida, Shintaro Sato, Harold Marcotte

Pharmaceutics· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic and immunologic evaluation of children with inborn errors of immunity and severe or critical COVID-19.
Hassan Abolhassani, Samaneh Delavari, Nils Landegren, Sima Shokri, Paul Bastard, Harold Marcotte

J Allergy Clin Immunol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mucosal IgA against SARS-CoV-2 Omicron Infection.
Fanglei Zuo, Harold Marcotte, Lennart Hammarström, Qiang Pan-Hammarström

N Engl J Med· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human neutralizing antibodies to cold linear epitopes and to subdomain 1 of SARS-CoV-2.
Filippo Bianchini, Virginia Crivelli, Morgan E Abernathy, Concetta Guerra, Martin Palus, Harold Marcotte

bioRxiv· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Limited cross-variant neutralization after primary Omicron infection: consideration for a variant-containing booster.
Harold Marcotte, Lennart Hammarström, Qiang Pan-Hammarström

Signal Transduct Target Ther· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant.
Fanglei Zuo, Hassan Abolhassani, Likun Du, Antonio Piralla, Federico Bertoglio, Harold Marcotte

Nat Commun· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inherited IFNAR1 Deficiency in a Child with Both Critical COVID-19 Pneumonia and Multisystem Inflammatory Syndrome.
Hassan Abolhassani, Nils Landegren, Paul Bastard, Marie Materna, Mohammadreza Modaresi, Harold Marcotte

J Clin Immunol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant.
Maren Schubert, Federico Bertoglio, Stephan Steinke, Philip Alexander Heine, Mario Alberto Ynga-Durand, Harold Marcotte

BMC Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunity to SARS-CoV-2 up to 15 months after infection.
Harold Marcotte, Antonio Piralla, Fanglei Zuo, Likun Du, Irene Cassaniti

iScience· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
X
X-Linked TLR7 Deficiency Underlies Critical COVID-19 Pneumonia in a Male Patient with Ataxia-Telangiectasia.
Hassan Abolhassani, Ahmad Vosughimotlagh, Takaki Asano, Nils Landegren, Bertrand Boisson, Harold Marcotte

J Clin Immunol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2-specific B- and T-cell immunity in a population-based study of young Swedish adults.
Sophia Björkander, Likun Du, Fanglei Zuo, Sandra Ekström, Yating Wang, Harold Marcotte

J Allergy Clin Immunol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody therapy for COVID-19.
Lennart Hammarström, Harold Marcotte, Antonio Piralla, Fausto Baldanti, Qiang Pan-Hammarström

Curr Opin Allergy Clin Immunol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing mechanistic understanding and bioengineering of probiotic lactobacilli and bifidobacteria by genome editing.
Fanglei Zuo, Harold Marcotte

Curr Opin Biotechnol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6-8 months after the infection.
Natalia Sherina, Antonio Piralla, Likun Du, Hui Wan, Makiko Kumagai-Braesch, Harold Marcotte

Med· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis